Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANGH | Anghami | $3.77 | $1.45 | 62.58% | 41.8M | $16M | $2.25$8.40 |
| ESHA | Esh Acquisition Corp. | $23.12 | $8.74 | 60.78% | 7.5M | $56M | $10.76$27.00 |
| SIDU | Sidus Space | $4.11 | $1.44 | 53.88% | 136.1M | $94M | $0.63$4.23 |
| VNDA | Vanda Pharmaceuticals | $8.97 | $1.94 | 27.60% | 397.4K | $415M | $3.81$9.60 |
| BYFC | Broadway Financial | $7.46 | $1.45 | 24.13% | 128.8K | $55M | $5.51$9.46 |
| AXSM | Axsome Therapeutics | $183.38 | $34.59 | 23.25% | 110K | $7.5B | $79.19$184.25 |
| BENF | Beneficient | $6.98 | $1.22 | 21.09% | 198.7K | $81M | $1.75$12.48 |
| AEI | Alset | $3.28 | $0.54 | 19.71% | 114.9K | $107M | $0.70$4.55 |
| LPCN | Lipocine | $7.84 | $1.27 | 19.35% | 305.7K | $36M | $2.52$7.85 |
| ALCY | Alchemy Investments Acquisition Corp 1 | $14.33 | $2.25 | 18.58% | 588.5K | $51M | $10.25$14.83 |
Related Articles
Featured Article
2 Under-the-Radar Stocks to Buy Heading Into 2026
Prosper Junior Bakiny|Dec 1, 2025
These drugmakers are poised to profit from their innovative engines.
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
Prosper Junior Bakiny|Sep 30, 2025
Both should have significant catalysts by the end of the decade.
Advertisement
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market.
1 Under-the-Radar Biotech Stock to Buy and Hold
Prosper Junior Bakiny|Sep 29, 2024
It could be an industry giant in the making.
Should You Buy This Sinking Stock on the Dip?
Prosper Junior Bakiny|Jun 27, 2024
The biotech isn't having the best year.
Prediction: These 2 Growth Stocks Could Triple By 2030
Prosper Junior Bakiny|May 11, 2024
These companies have a habit of silencing the bears.
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks.
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Sushree Mohanty|Aug 24, 2023
Today's market loser could be tomorrow's market winner.
